Last edition
News about Market
Lupin Spins Out 2 Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
Lupin has spun off two oncology programs into Kaveri Therapeutics, retaining a significant equity stake while providing seed funding and exclusive program rights.
Market | 22/07/2026 | By News Bureau
The collaboration between Insilico Medicine and Bora Pharmaceuticals is valued at over USD 2.5 billion if fully implemented and aims to accelerate the discovery, development and commercialisation of next-generation therapies while expanding AI adoption across the pharmaceutical value chain.
Market | 16/07/2026 | By News Bureau | 118
India-UK FTA to Boost Pharma Exports Beyond USD 981 Million in FY2026-27: Pharmexcil
India-UK FTA is expected to boost India's pharmaceutical exports to the UK beyond USD 981 million in FY2026-27, building on strong export growth, according to Pharmexcil.
Market | 16/07/2026 | By News Bureau | 107
UK and EU Drugs Agency Sign Pact to Strengthen Response to Emerging Drug Threats
The UK government and the European Union Drugs Agency (EUDA) have signed a new cooperation agreement to enhance intelligence sharing on emerging drug threats, strengthen public health protection and improve coordinated action against illicit drug trafficking across Europe.
Market | 15/07/2026 | By News Bureau
AstraZeneca Enters into Global License Agreement with with Dizal Pharmaceutical for Zegfrovy
AstraZeneca has entered a global licensing agreement with Dizal Pharmaceutical for Zegfrovy, expanding its EGFR-targeted lung cancer portfolio.
Market | 15/07/2026 | By News Bureau
Sun Pharma Receives Approval to Manufacture and Market Generic Semaglutide in South Africa
Sun Pharma has received approval to manufacture and market generic semaglutide in South Africa, available as a once-weekly pre-filled multi-dose injectable pen in 2 strengths.
Market | 15/07/2026 | By News Bureau
NATCO Pharma Acquires Additional 13.25 Percent Stake in Adcock Ingram
NATCO Pharma has completed the acquisition of an additional 13.25 percent stake in South Africa's Adcock Ingram, strengthening its strategic investment in the pharmaceutical company.
Market | 15/07/2026 | By News Bureau | 149
Emcure Takes Full Ownership of Gennova, Strengthens Focus on Biologics and Biosimilars
Emcure Pharmaceuticals has acquired the remaining minority stake in Gennova Biopharmaceuticals, making it a wholly owned subsidiary while appointing Samit Mehta to lead the company’s next phase of growth in biologics and biosimilars.
Market | 14/07/2026 | By News Bureau
Santhera Expands Agamree Distribution Partnership with Biomedica Across Five Additional Markets
Santhera Pharmaceuticals has expanded its exclusive distribution partnership with Biomedica to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, extending access to Agamree (vamorolone) for patients with Duchenne muscular dystrophy across additional underserved markets.
Market | 14/07/2026 | By News Bureau
Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue
Torrent Pharmaceuticals has initiated a recall of select batches of Semalix Injection 2 mg and 4 mg after certain semaglutide batches failed quality specifications due to an API-related issue.
Market | 10/07/2026 | By News Bureau | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy